Clusterin is overexpressed during tissue and cell involution and downregulated in proliferating cells. Its role in cell survival, cell death and neoplastic transformation remains debated. We studied the expression and distribution of clusterin mRNA and protein in human prostate carcinoma (CaP) specimens of different degrees of malignancy. Fresh CaP specimens were obtained from 25 patients subjected to long-term androgen ablation before surgery. Clusterin expression was studied by Northern and Western analysis, in situ hybridization and immunohistochemistry, in comparison with Gas I and histone H3 mRNA (markers of cell quiescence and S phase of the cell cycle, respectively). Clusterin is downregulated in CaP in comparison with matched benign controls. In low-grade CaP, clusterin colocalized with Gas I to the stromal compartment, and in some glands, the basal lamina was heavily stained. In high-grade CaP clusterin stained the remnants of stromal matrix while histone H3 localized to cancer cells, which were very rarely clusterin positive. High clusterin expression was found in the branches of a nerve infiltrated by tumor. The periglandular clusterin expression found in low-grade CaP could result from induction of quiescence and/or apoptosis of prostatic fibroblasts lining those glands in which tumor invasion is at an initial stage, involving basal lamina. In advanced CaP, the staining of the remnants of the extracellular matrix suggests a role for clusterin in the process of dismantling the stromal organization caused by cancer progression.

Clusterin (SGP-2, ApoJ) expression is downregulated in low- and high-grade human prostate cancer / Scaltriti, Maurizio; M., Brausi; A., Amorosi; A., Caporali; D'Arca, Domenico; Astancolle, Serenella; Corti, Arnaldo; S., Bettuzzi. - In: INTERNATIONAL JOURNAL OF CANCER. - ISSN 0020-7136. - STAMPA. - 108:1(2004), pp. 23-30. [10.1002/ijc.11496]

Clusterin (SGP-2, ApoJ) expression is downregulated in low- and high-grade human prostate cancer

SCALTRITI, Maurizio;D'ARCA, Domenico;ASTANCOLLE, Serenella;CORTI, Arnaldo;
2004

Abstract

Clusterin is overexpressed during tissue and cell involution and downregulated in proliferating cells. Its role in cell survival, cell death and neoplastic transformation remains debated. We studied the expression and distribution of clusterin mRNA and protein in human prostate carcinoma (CaP) specimens of different degrees of malignancy. Fresh CaP specimens were obtained from 25 patients subjected to long-term androgen ablation before surgery. Clusterin expression was studied by Northern and Western analysis, in situ hybridization and immunohistochemistry, in comparison with Gas I and histone H3 mRNA (markers of cell quiescence and S phase of the cell cycle, respectively). Clusterin is downregulated in CaP in comparison with matched benign controls. In low-grade CaP, clusterin colocalized with Gas I to the stromal compartment, and in some glands, the basal lamina was heavily stained. In high-grade CaP clusterin stained the remnants of stromal matrix while histone H3 localized to cancer cells, which were very rarely clusterin positive. High clusterin expression was found in the branches of a nerve infiltrated by tumor. The periglandular clusterin expression found in low-grade CaP could result from induction of quiescence and/or apoptosis of prostatic fibroblasts lining those glands in which tumor invasion is at an initial stage, involving basal lamina. In advanced CaP, the staining of the remnants of the extracellular matrix suggests a role for clusterin in the process of dismantling the stromal organization caused by cancer progression.
2004
108
1
23
30
Clusterin (SGP-2, ApoJ) expression is downregulated in low- and high-grade human prostate cancer / Scaltriti, Maurizio; M., Brausi; A., Amorosi; A., Caporali; D'Arca, Domenico; Astancolle, Serenella; Corti, Arnaldo; S., Bettuzzi. - In: INTERNATIONAL JOURNAL OF CANCER. - ISSN 0020-7136. - STAMPA. - 108:1(2004), pp. 23-30. [10.1002/ijc.11496]
Scaltriti, Maurizio; M., Brausi; A., Amorosi; A., Caporali; D'Arca, Domenico; Astancolle, Serenella; Corti, Arnaldo; S., Bettuzzi
File in questo prodotto:
File Dimensione Formato  
Scaltriti_et_al-2004-International_Journal_of_Cancer.pdf

Accesso riservato

Descrizione: Articolo principale
Tipologia: Versione pubblicata dall'editore
Dimensione 639.05 kB
Formato Adobe PDF
639.05 kB Adobe PDF   Visualizza/Apri   Richiedi una copia
Pubblicazioni consigliate

Licenza Creative Commons
I metadati presenti in IRIS UNIMORE sono rilasciati con licenza Creative Commons CC0 1.0 Universal, mentre i file delle pubblicazioni sono rilasciati con licenza Attribuzione 4.0 Internazionale (CC BY 4.0), salvo diversa indicazione.
In caso di violazione di copyright, contattare Supporto Iris

Utilizza questo identificativo per citare o creare un link a questo documento: https://hdl.handle.net/11380/303707
Citazioni
  • ???jsp.display-item.citation.pmc??? 24
  • Scopus 96
  • ???jsp.display-item.citation.isi??? 91
social impact